Related Experiment Video

Updated: Jun 17, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Susceptibility and resistance in the genesis of asbestos-related mesothelioma

Claudio Bianchi1, Tommaso Bianchi

  • 1Center for the Study of Environmental Cancer, Italian League Against Cancer, Hospital of Monfalcone, 34074 Monfalcone, Italy.

Indian Journal of Occupational and Environmental Medicine
|December 31, 2009
PubMed

Insights

Host factors, not just asbestos exposure, influence malignant mesothelioma development. Genetic susceptibility and immune mechanisms play key roles in cancer resistance or vulnerability. Strengthening immunity may prevent mesothelioma.

Area of Science:

  • Oncology
  • Immunology
  • Environmental Health

Background:

  • Asbestos exposure is the primary cause of malignant mesothelioma.
  • However, only a fraction of exposed individuals develop the disease, indicating host factors are crucial.
  • Familial clustering and increased incidence of other malignancies in mesothelioma patients suggest genetic susceptibility and broader cancer vulnerability.

Purpose of the Study:

  • To investigate the role of host factors, including genetic susceptibility and immune mechanisms, in malignant mesothelioma development.
  • To explore the observed resistance to asbestos-induced cancer in some individuals.
  • To understand the link between immune function and mesothelioma pathogenesis.

Main Methods:

  • Review of existing literature on mesothelioma etiology and host factors.
  • Analysis of familial mesothelioma cases and co-occurrence of other malignancies.
  • Examination of immune status in mesothelioma patients and asbestos-exposed individuals with varying outcomes.

Main Results:

  • A significant proportion of mesothelioma cases show familial aggregation, supporting genetic susceptibility (approx. 4%).
  • Mesothelioma patients exhibit higher rates of other cancers, indicating a general cancer predisposition.
  • Some individuals demonstrate remarkable resistance to asbestos carcinogenicity, even with heavy exposure, linked to efficient immune responses.

Conclusions:

  • Host factors, particularly genetic predisposition and immune system efficiency, significantly modulate the risk of developing malignant mesothelioma after asbestos exposure.
  • The existence of resistance suggests that enhancing natural defense mechanisms could be a viable strategy for mesothelioma prevention in asbestos-exposed populations.
Keywords:
Asbestosfamilial cancerhost factorsimmune impairmentmesotheliomaresistancesusceptibility

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...